Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: a randomized crossover study.
about
Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial.The gut-kidney connection in advanced chronic kidney disease.Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.The intestine and the kidneys: a bad marriage can be hazardous.Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption.The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease.The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.Intestinal adsorption of uraemic toxins: a new strategy for anaemia management?Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
P2860
Q34325810-C1D3C557-383A-4DC3-A5BE-98F85E22B3C9Q36397047-DA2224EA-C7FF-41BB-BC70-5D058C2D738AQ37468522-1F30C54C-07B5-45DD-9835-F5068E216903Q38393212-2DEEDC4F-275B-4BD1-8074-92619CB6C623Q38659702-F8815D45-1695-4896-9F7C-D73BE2B35F3BQ38666170-F07AAC43-261F-42DB-BD26-08E02B116EBDQ41190048-11D8F263-AE7E-4A9F-8A83-95135B33C6F6Q45324913-A72B702C-082D-4CB7-941B-82523B409CEBQ47851147-212CCEF6-A221-4444-9B8B-FC35E535B83CQ51738037-6EB20192-3DA9-443B-B776-67AA21730862Q54173895-34453154-427F-4CBA-B46A-9E1DE49493DBQ55476982-90D7D4D7-B42E-4480-9F61-832E5AEA61AAQ58749760-5778292B-A3AC-4802-BD36-D65FBF3F7C62
P2860
Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: a randomized crossover study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@en
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@nl
type
label
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@en
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@nl
prefLabel
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@en
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@nl
P2093
P2860
P356
P1476
Oral adsorbent AST-120 potenti ...... a randomized crossover study.
@en
P2093
Chi-Jen Tsai
Chin-Chan Lee
Chio-Yin Sun
Mai-Szu Wu
P2860
P304
P356
10.1093/NDT/GFU061
P407
P577
2014-04-08T00:00:00Z